Security key
87164F105
Syndax Pharmaceuticals Inc - Common Stock, par value $0.0001 per share (SNDX)
CUSIP: 87164F105
Q4 2022 13F Holders as of 31 Dec 2022
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Total 13F shares
- 71,468,832
- Total 13F value
- $1,818,847,118
- Share change
- +10,250,881
- Put/Call ratio
- 96%
- SEC-reported price per share
- $25.45
- Number of holders
- 159
- Value change
- +$262,720,878
- Number of buys
- 96
- Number of sells
- 47
- Shares outstanding
- 86,328,130
Holder snapshot
7 signals
Show 1 more signal
Security identity
1 source field
Report period
Q4 2022
Institutions
159
Top holders
10
SNDX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2023
Previous quarter: Q3 2022
Syndax Pharmaceuticals Inc SEC filings
Syndax Pharmaceuticals Inc company facts
Broader feeds
Reporting periods
Holder history for CUSIP 87164F105
Recent filing periods:
Ownership snapshot
Top reported holders of SNDX - Syndax Pharmaceuticals Inc - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Avidity Partners Manageme...
Disclosed value leader
Avidity Partners Manageme...
Comparable rows
15/15
Latest evidence
30 Sep 2022
13F
Lead comparable stake: 6.5%
Showing 1-6 of 15 holder rows.
Quick read
Avidity Partners Management LP leads the comparable SEC ownership view at 6.5%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Comparable ownership
Top 5
Avidity Partners Management LP
6.5%
WELLINGTON MANAGEMENT GROUP LLP
5.1%
BlackRock Finance, Inc.
4.8%
Frazier Life Sciences Management,...
4%
VANGUARD GROUP INC
3.2%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Avidity Partners Management LP |
13F
Company
|
6.5%
|
$134,253,000
5,586,900 shares
|
— | 30 Sep 2022 |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
Company
|
5.1%
|
$105,429,000
4,387,440 shares
|
— | 30 Sep 2022 |
| BlackRock Finance, Inc. |
13F
Company
|
4.8%
|
$99,476,000
4,139,617 shares
|
— | 30 Sep 2022 |
| Frazier Life Sciences Management, L.P. |
13F
Company
|
4%
|
$82,010,000
3,412,838 shares
|
— | 30 Sep 2022 |
| VANGUARD GROUP INC |
13F
Company
|
3.2%
|
$67,339,000
2,802,299 shares
|
— | 30 Sep 2022 |
| STATE STREET CORP |
13F
Company
|
3%
|
$62,897,000
2,617,437 shares
|
— | 30 Sep 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2022
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
159
Shares
71,468,832
Rows available
159
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2022 vs Q3 2022 Across Filers
Q3 2022 holders
136
Q4 2022 holders
159
Holder diff
23
| Investor | Q3 2022 Shares | Q4 2022 Shares | Share Diff | Share Chg % | Q3 2022 value | Q4 2022 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend